The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake

Meredith A. Hawkins, Ivo Angelov, Rong Liu, Nir Barzilai, Luciano Rossetti

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

To delineate the biochemical mechanism by which increased availability of GlcN impairs insulin action on skeletal muscle glucose uptake, we replenished the uridine pool during GIcN administration. Co-infusion of uridine with GlcN prevented the GlcN-induced fall in skeletal muscle UDP- glucose levels (24.9 ± 5.3 versus 10.1 ± 2.9 nmol/g; p < 0.01) and further increased the skeletal muscle UDP-GlcNAc levels (198.4 ± 26.3 versus 96.0 ± 8.4 nmol/g; p < 0.01). Greater reductions in the rates of glucose infusion (~53%), glucose uptake (~43%), and glycogen synthesis (~60%) were observed with the addition of uridine. Similarly, the infusion of uridine alone markedly increased the skeletal muscle levels of both UDP-glucose (55.2 ± 14.2 versus 17.8 ± 6.1 nmol/g; p < 0.01) and UDP-GlcNAc (86.8 ± 8.8 versus 35.9 ± 8.4 nmol/g;p < 0.05) and induced marked insulin resistance. The decrease in insulin action on peripheral glucose uptake was highly correlated with the increase in skeletal muscle UDP-GlcNAc levels. Finally, immunoisolation of GLUT4-containing vesicles revealed that the rate of labeled GlcN incorporation was ~100-fold greater following GIcN compared with saline infusions (p < 0.01). We suggest that the marked reduction in insulin action induced by GlcN and uridine is mediated by increased accumulation of muscle UDP-N-acetylhexosamines, perhaps via altered glycosylation of protein(s) in GLUT4-containing vesicles.

Original languageEnglish (US)
Pages (from-to)4889-4895
Number of pages7
JournalJournal of Biological Chemistry
Volume272
Issue number8
DOIs
StatePublished - Feb 21 1997

Fingerprint

Uridine Diphosphate N-Acetylglucosamine
Uridine Diphosphate
Acetylglucosamine
Uridine
Muscle
Skeletal Muscle
Insulin
Tissue
Glucose
Uridine Diphosphate Glucose
Glycosylation
Glycogen
Insulin Resistance
Muscles
Availability

ASJC Scopus subject areas

  • Biochemistry

Cite this

The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. / Hawkins, Meredith A.; Angelov, Ivo; Liu, Rong; Barzilai, Nir; Rossetti, Luciano.

In: Journal of Biological Chemistry, Vol. 272, No. 8, 21.02.1997, p. 4889-4895.

Research output: Contribution to journalArticle

@article{297b9a543d6b4a65a0f33d35287f4c2b,
title = "The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake",
abstract = "To delineate the biochemical mechanism by which increased availability of GlcN impairs insulin action on skeletal muscle glucose uptake, we replenished the uridine pool during GIcN administration. Co-infusion of uridine with GlcN prevented the GlcN-induced fall in skeletal muscle UDP- glucose levels (24.9 ± 5.3 versus 10.1 ± 2.9 nmol/g; p < 0.01) and further increased the skeletal muscle UDP-GlcNAc levels (198.4 ± 26.3 versus 96.0 ± 8.4 nmol/g; p < 0.01). Greater reductions in the rates of glucose infusion (~53{\%}), glucose uptake (~43{\%}), and glycogen synthesis (~60{\%}) were observed with the addition of uridine. Similarly, the infusion of uridine alone markedly increased the skeletal muscle levels of both UDP-glucose (55.2 ± 14.2 versus 17.8 ± 6.1 nmol/g; p < 0.01) and UDP-GlcNAc (86.8 ± 8.8 versus 35.9 ± 8.4 nmol/g;p < 0.05) and induced marked insulin resistance. The decrease in insulin action on peripheral glucose uptake was highly correlated with the increase in skeletal muscle UDP-GlcNAc levels. Finally, immunoisolation of GLUT4-containing vesicles revealed that the rate of labeled GlcN incorporation was ~100-fold greater following GIcN compared with saline infusions (p < 0.01). We suggest that the marked reduction in insulin action induced by GlcN and uridine is mediated by increased accumulation of muscle UDP-N-acetylhexosamines, perhaps via altered glycosylation of protein(s) in GLUT4-containing vesicles.",
author = "Hawkins, {Meredith A.} and Ivo Angelov and Rong Liu and Nir Barzilai and Luciano Rossetti",
year = "1997",
month = "2",
day = "21",
doi = "10.1074/jbc.272.8.4889",
language = "English (US)",
volume = "272",
pages = "4889--4895",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "8",

}

TY - JOUR

T1 - The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake

AU - Hawkins, Meredith A.

AU - Angelov, Ivo

AU - Liu, Rong

AU - Barzilai, Nir

AU - Rossetti, Luciano

PY - 1997/2/21

Y1 - 1997/2/21

N2 - To delineate the biochemical mechanism by which increased availability of GlcN impairs insulin action on skeletal muscle glucose uptake, we replenished the uridine pool during GIcN administration. Co-infusion of uridine with GlcN prevented the GlcN-induced fall in skeletal muscle UDP- glucose levels (24.9 ± 5.3 versus 10.1 ± 2.9 nmol/g; p < 0.01) and further increased the skeletal muscle UDP-GlcNAc levels (198.4 ± 26.3 versus 96.0 ± 8.4 nmol/g; p < 0.01). Greater reductions in the rates of glucose infusion (~53%), glucose uptake (~43%), and glycogen synthesis (~60%) were observed with the addition of uridine. Similarly, the infusion of uridine alone markedly increased the skeletal muscle levels of both UDP-glucose (55.2 ± 14.2 versus 17.8 ± 6.1 nmol/g; p < 0.01) and UDP-GlcNAc (86.8 ± 8.8 versus 35.9 ± 8.4 nmol/g;p < 0.05) and induced marked insulin resistance. The decrease in insulin action on peripheral glucose uptake was highly correlated with the increase in skeletal muscle UDP-GlcNAc levels. Finally, immunoisolation of GLUT4-containing vesicles revealed that the rate of labeled GlcN incorporation was ~100-fold greater following GIcN compared with saline infusions (p < 0.01). We suggest that the marked reduction in insulin action induced by GlcN and uridine is mediated by increased accumulation of muscle UDP-N-acetylhexosamines, perhaps via altered glycosylation of protein(s) in GLUT4-containing vesicles.

AB - To delineate the biochemical mechanism by which increased availability of GlcN impairs insulin action on skeletal muscle glucose uptake, we replenished the uridine pool during GIcN administration. Co-infusion of uridine with GlcN prevented the GlcN-induced fall in skeletal muscle UDP- glucose levels (24.9 ± 5.3 versus 10.1 ± 2.9 nmol/g; p < 0.01) and further increased the skeletal muscle UDP-GlcNAc levels (198.4 ± 26.3 versus 96.0 ± 8.4 nmol/g; p < 0.01). Greater reductions in the rates of glucose infusion (~53%), glucose uptake (~43%), and glycogen synthesis (~60%) were observed with the addition of uridine. Similarly, the infusion of uridine alone markedly increased the skeletal muscle levels of both UDP-glucose (55.2 ± 14.2 versus 17.8 ± 6.1 nmol/g; p < 0.01) and UDP-GlcNAc (86.8 ± 8.8 versus 35.9 ± 8.4 nmol/g;p < 0.05) and induced marked insulin resistance. The decrease in insulin action on peripheral glucose uptake was highly correlated with the increase in skeletal muscle UDP-GlcNAc levels. Finally, immunoisolation of GLUT4-containing vesicles revealed that the rate of labeled GlcN incorporation was ~100-fold greater following GIcN compared with saline infusions (p < 0.01). We suggest that the marked reduction in insulin action induced by GlcN and uridine is mediated by increased accumulation of muscle UDP-N-acetylhexosamines, perhaps via altered glycosylation of protein(s) in GLUT4-containing vesicles.

UR - http://www.scopus.com/inward/record.url?scp=0031046187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031046187&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.8.4889

DO - 10.1074/jbc.272.8.4889

M3 - Article

C2 - 9030547

AN - SCOPUS:0031046187

VL - 272

SP - 4889

EP - 4895

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 8

ER -